https://tonic.inserm.fr/wp-content/uploads/2021/01/photo-Nina-Colitti-150x150.jpg

Nina COLITTI

Doctorante

    Abstracts rédigés ou co-rédigés

  • > Intranasal administration of enteric glia is safe and promotes neural tissue reconstruction in a rat model of brain injury

    Nina Colitti, Maylis Combeau, Franck Desmoulin, Lorenne Robert, Costanza Simoncini, Edwige Rice, Isabelle Loubinoux and Carla Cirillo

    FENS Regional Meeting FRM 2023

    Algarve Portugal

  • > Regenerative Brain Scaffold

    Maylis Combeau, Nina Colitti, Julien Clauzel, Lorenne Robert, Wafae Labriji, Franck Desmoulin, Isabelle Loubinoux

    FENS Regional Meeting FRM 2023

    Algarve Portugal

  • > Use of pCASL MRI sequence to study brain perfusion and vascular permeability after Blood Brain Barrier opening: limitations and perspectives.

    Wafae Labriji, Julien Clauzel, Nina Colitti, Carla Cirillo, Isabelle Loubinoux, Franck Desmoulin

    FENS 2022 (Federation of European Neurosciences Societies) –

     

  • > FIVE-WEEK INTRANASAL NERVE GROWTH FACTOR TREATMENT IS SAFE AND FAVORS BRAIN NEUROGENESIS

    Nina Colitti, Franck Desmoulin, Wafae Labriji, Alice Le Friec, Lorenne Robert, Amandine Michaux, Fabrice Conchou, Carla Cirillo, and Isabelle Loubinoux,

    FENS 2022 (Federation of European Neurosciences Societies) _ 9-13 juillet 2022 à Paris

     

  • > FIVE-WEEK NERVE GROWTH FACTOR TREATMENT IS SAFE FOR BRAIN REPAIR

    Nina Colitti, Franck Desmoulin, Wafae Labriji, Alice Le Friec, Lorenne Robert, Amandine Michaux, Fabrice Conchou, Carla Cirillo, and Isabelle Loubinoux,

    ADPD 2022 (International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders)  – 14-20 mars 2022 , Barcelone, Espagne.

    Publications rédigées ou co-rédigées

  • > 67- Diffusion tensor imaging and gray matter volumetry to evaluate cerebral remodeling processes after a pure motor stroke: a longitudinal study.

    Loubinoux I, Lafuma M, Rigal J, Colitti N, Albucher JF, Raposo N, Planton M, Olivot JM, Chollet F.

    J Neurol. 2024 Sep 3. doi: 10.1007/s00415-024-12648-y.
  • > 55- Long-Term Intranasal Nerve Growth Factor Treatment Favors Neuron Formation in de novo Brain Tissue.

    Colitti N, Desmoulin F, Le Friec A, Labriji W, Robert L, Michaux A, Conchou F, Cirillo C, Loubinoux I.

    Front Cell Neurosci. 2022 Jul 19;16:871532. doi: 10.3389/fncel.2022.871532.
  • > 44- Present and future avenues of cell-based therapy for brain injury: The enteric nervous system as a potential cell source.

    Hacene S, Le Friec A, Desmoulin F, Robert L, Colitti N, Fitremann J, Loubinoux I, Cirillo C.

    Brain Pathol. 2022 Jun 30:e13105. doi: 10.1111/bpa.13105.
  • Administration intranasale de NGF dans l’objectif d’améliorer la récupération sensorimotrice après lésion intracérébrale chez le rat. Suivi par tests comportementaux , IRM et histologiques. En cours de publication
  • Stratégie thérapeutique dans la régénération cérébrale : cellules neuronales périphériques et bio-implants 3D pour la récupération fonctionnelle.